Quick Answer
Evommune, Inc. reported Net Income of -$68.87 million for fiscal year 2025.
Evommune, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$68.87M | -3.1% |
| 2024 | -$66.81M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.47M | +21.6% | +21.6% |
| September 30, 2024 | -$15.92M | — | — |
- Evommune, Inc. showed a decrease of -3.1% in Net Income compared to the prior fiscal year.
- Over the 2024–2025 period, Evommune, Inc.’s net income has declined by 3.1% (from -$66.81 million to -$68.87 million).
- The most recent figure is from Evommune, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: